Want to join the conversation?
$PRGS said it expects FY16 non-GAAP revenue in the range of $412-418MM and 3Q16 non-GAAP revenue of $103-106MM. Non-GAAP EPS is expected in the range of $1.57-1.63 in FY16, and $0.43-0.46 in 3Q16. For FY16, the company expects effective tax rate on a non-GAAP basis of 32-33%. $PRGS expects non-GAAP adjusted free cash flow of $80-85MM in FY16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?